How BioPharma SHAKTI can transform biologics with non-animal models
admin
0
0
A class of drugs called biologics is becoming more popular worldwide against many chronic diseases; on the flip side, animal models not do reliably predict their safety and efficacy, prompting scientists to shift to bioengineered, human-relevant systems such as organoids, organ-on-a-chip, and 3D bioprinting
